This site uses cookies in order to function as expected. By continuing, you are agreeing to our 
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Study for the implementation in Belgium of the Nagoya Protocol on Access and Benefit‐sharing (ABS) to the Convention on Biological Diversity
ABS potentially encompasses a large range of issues extending far beyond sole environmental matters, including market regulation and access, international trade, agriculture, health, development cooperation, research & development and innovation. As a consequence, the future implementation of the Nagoya Protocol could be relevant to several departments and several levels of competence in Belgium.
| Concerned URL | http://www.biodiv.be/implementation/cross-cutting-issues/abs/20130321-final-report-np-abs-be.pdf |
|---|---|
| Release date | 08/07/2013 |
The final report of the study for the implementation in Belgium of the Nagoya Protocol on Access and Benefit‐sharing (ABS) to the Convention on Biological Diversity (CBD) is now available.
The need for this study was decided by the Interministerial Conference on the Environment of 31st March 2011 to allow for an early ratification by Belgium of the Nagoya Protocol. This is in support of the overall goal to implement the CBD since the 2010 Nagoya Protocol is a protocol to the CBD.
The objective of this study is to contribute to the ratification and the implementation in Belgium of the Nagoya Protocol on ABS, thereby contributing to the conservation of biological diversity and the sustainable use of its components. It also aims to identify and evaluate the possible consequences for the Belgian national legislation and regulation, as well as for Belgian stakeholders, resulting from the implementation of the Nagoya Protocol in Belgium.
The Study is in English and also contains an Executive Summary in English, French and Dutch http://www.biodiv.be/implementation/cross-cutting-issues/abs/20130321-final-report-np-abs-be.pdf
For more information on the Nagoya Protocol, please visit http://www.biodiv.be/convention/nagoya-protocol-access-and-benefit-sharing